|Title:||Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists|
|Abstract:||Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.|
|Inventor(s):||Finkelstein; Joseph A. (Philadelphia, PA), Keenan; Richard M. (Malvern, PA), Weinstock; Joseph (Phoenixville, PA)|
|Assignee:||SmithKline Beecham Corporation (Philadelphia, PA)|
Patent Claim Types:|
see list of patent claims
|Compound; Composition; Use;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|African Regional IP Organization (ARIPO)||525||► subscribe|
|African Regional IP Organization (ARIPO)||526||► subscribe|
|African Regional IP Organization (ARIPO)||527||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.